Heart health check: new study tests postpartum program to cut cardiovascular risk
NCT ID NCT07420465
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 200 pregnant women in Ghana from their third trimester through six months after birth. It measures blood pressure and artery stiffness to see if a structured education program on heart health, nutrition, and stress management can reduce long-term cardiovascular risk. The goal is to develop a scalable screening and intervention strategy for new mothers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Postpartum Cardiovascular Disease (CVD) Risk Reduction Program (behavioral intervention)
What this could lead to
If successful, this could lead to a simple, scalable program to help new mothers lower their heart disease risk after pregnancy.
What could go wrong
This is an early-stage study with no phase, so results are preliminary. The program may not show significant improvements in blood pressure or arterial stiffness, and findings from Ghana may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
School of Public Health
Accra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact